Bio Lifesciences

Wednesday, 24 April 2024

Latest News for: Bio lifesciences

Edit

Single-Cell Multi-Omics Projected to Reach US$ 3377.5 Mn by 2030 | CAGR of 9.8%

Pharmiweb 05 Mar 2024

Market Overview ... Key Takeaways ... Drivers ... Restraints ... Challenges ... 10x Genomics 1CellBio MissionBio NanoString Technologies Fluidigm Corporation Fluxion Biosciences Bio-Rad Laboratories Celsee BGI Genomics GE LifeSciences Illumina Takara Bio QIAGEN N.V ... 1 ... A.

Edit

Europe’s Advanced Therapy Medicinal Products Market Poised for Significant Growth reaching US$ 24 billion by 2032 | Future Market Insights

Pharmiweb 28 Feb 2024

Advanced Therapy Medicinal Products Market ... According to the report, the global sales of the Advanced therapy medicinal products Market in 2022 amounted to US$ 9.8 billion ... Bluebird Bio Inc ... Celgene Corporation Gilead Lifesciences Inc ... Ltd ... By Region ... T ... .

Edit

Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI

GetNews 26 Feb 2024

Earlier in February 2024, Dyadic garnered attention for its partnership with Cygnus Technologies, a division of Maravai LifeSciences (NASDAQ. MRVI) and on Friday, February 23, 2024, Maravai LifeSciences (NASDAQ ... Intelligent Bio Solutions Inc.

Edit

Here’s a new way to consider value for stocks in the S&P 500

Market Watch 22 Jan 2024

Investing and trading are not the same thing. A lot of financial-media coverage of the stock market is geared toward the short-term concerns of traders trying to buy or sell at the best prices ... ROA 10-year avg ... Edwards Lifesciences Corp ... Bio-Techne Corp.

Edit

Predictive Oncology to Participate in Upcoming San Francisco Conferences

The Eagle-Tribune 02 Jan 2024

PITTSBURGH, Jan ... (NASDAQ ... PT. Company management will also participate in the 13th Annual LifeSci Partners Corporate Access Event and BIO Partnering @ JPM Week 2024 ... link here13th Annual LifeSci Partners Corporate Access Event ... LifeSci Advisors, LLC ... .

Edit

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - COVID-19 Impact, Regions of ...

Tyler Morning Telegraph 27 Dec 2023

HungaryDiaSorinEdico Genome (Illumina)Eiken Chemical Co., LtdEKF Diagnostics Holdings PlcELITech Group S.A.S.Epic SciencesEpigenomics AGERBA Diagnostics, Inc.FujirebioFujirebio Diagnostics, ...

Edit

Aiolos Bio Strengthens and Expands Leadership Team with Key Appointments

Hastings Tribune 12 Dec 2023

van der Merwe brings more than two decades of R&D experience to Aiolos Bio, having led global development programs for multiple approved asthma biologics ... “I’m thrilled to be joining the talented team at Aiolos Bio,” said Dr ... About Aiolos Bio.

Edit

Global Advanced Therapy Medicinal Products Market is on the brink of substantial expansion, aiming for a valuation of US$ 39 Billion by 2032 | FMI

Pharmiweb 28 Nov 2023

Advanced Therapy Medicinal Products Market ... From 2022 to 2032, the market is projected to expand at a 15% CAGR, valued at US$ 39 billion ... Rising prevalence of chronic and genetic diseases ... Bluebird Bio, Inc ... Celgene Corporation Gilead Lifesciences, Inc ... .

Edit

Telesis Bio Reports Third Quarter 2023 Financial Results

The Eagle-Tribune 13 Nov 2023

13, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc ... Strengthened board of directors and management team.Appointed Greg Herrema, Senior Advisor to Novalis LifeSciences to the Telesis Bio board of directors in October 2023 ... About Telesis Bio ... Telesis Bio Inc.

Edit

Maravai LifeSciences Announces November 2023 Investor Conference Schedule

The Eagle-Tribune 09 Nov 2023

09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc ... A live webcast of the presentations will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events ... maravai@macdougall.bio.

Edit

Virtusa named a Major Player in IDC MarketScape for Life Sciences R&D RWE, RWD, Platforms, ...

Longview News-Journal 30 Oct 2023

Virtusa has recognized the transformative power of RWD and has harnessed it to deliver superior solutions across the Lifesciences industry. Capturing RWD bio-sample data from trial sites has been a key ...

Edit

AxoSim Extends Leadership in Human Organoids for Neurological Drug Discovery with Acquisition of StemoniX microBrain™ Technology

Longview News-Journal 24 Oct 2023

... associated assets of Vyant Bio's StemoniX subsidiary ... Jones Walker LLP served as legal counsel to AxoSim, Inc., and LifeSci Capital and Lowenstein Sandler LLP served as advisers to Vyant Bio, Inc.

Edit

Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023

The Eagle-Tribune 17 Oct 2023

17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc ... To participate in the conference call by telephone, dial (800) 715-9871 or (646) 307-1963 and reference Maravai LifeSciences, Conference ID 4621071.

Edit

Breaking Barriers: Regenerative Medicine Market’s Remarkable 23.9% CAGR Leading to US$85.3 Billion by 2032 | Reveals by FMI

Pharmiweb 05 Oct 2023

In a groundbreaking revelation, the global Regenerative Medicine Market is on the cusp of extraordinary expansion ... Key Takeaways ... Experts Today! ... Aspect Biosystems bluebird bio Kite Pharma Integra LifeSciences Holdings Corporation MEDIPOST Co., Ltd ... T ... .

Edit

Future Insights: Regenerative Medicine Market Poised for Impressive US$ 85.3 Billion Valuation by 2032 with 23.9% CAGR

Pharmiweb 27 Sep 2023

Furthermore, it is anticipated to achieve an impressive valuation of US$ 85.3 billion by 2032 ... Key Takeaways ... Experts Today! ... Competitive Landscape . ... Aspect Biosystems bluebird bio Kite Pharma Integra LifeSciences Holdings Corporation MEDIPOST Co., Ltd ... .